BLACK WEEKSInjektiopullot −15 % · kitit −10 % · muut −5 %koodillaIlmainen toimitus Saksaan alk. €200

Tämä sivu on käännetty automaattisesti, ja siinä voi olla virheitä. Onko suomi äidinkielesi? Otamme mielellämme vastaan palautetta ja korjauksia.Lähetä palautetta

The Peptide Desk The Peptide Desk
VIP Nasal, tuotekuva
Immune System

VIP Nasal

Immune System

  • Lähetetään Saksasta

Tilaus

Kappalehinta - Ilmainen toimitus Saksaan yli 200 €:n tilauksille Black Weeksin aikana
  • DHL seurannalla
  • Huomaamaton pakkaus

4.6/5 Trustpilotissa73 arvostelua

Haettu myös nimellä: VIP Nasenspray

Yhdellä silmäyksellä

VIP Nasal lukuina

Tietopankkimme keskeiset luvut.

Koko tietopankkiartikkeli
Class
Neuropeptide of 28 amino acidsimmune-regulating and vasodilating
Half-life
About 1 minute in bloodmeasured after intravenous infusion
Frequency
Dailyeach dose acts only briefly
Form
Ready-made nasal spray, 10mg in 5.4ml1.85mg/ml, about 185mcg per spray
Sizes
10 mg1 size in the shop

Tuotteelle VIP Nasal ei ole vielä laboratorioanalyysia. Äänestä sitäTestauta itse, me maksamme puoletKaikki laboratorioanalyysit

Tietoa

Kaikki aiheesta VIP Nasal

FAQ

Usein kysyttyä

Lähteet jokaiseen vastaukseen: tietopankkiartikkeli

Onko sinulla vielä kysyttävää?

Kirjoita meille, tiimimme auttaa sinua.

Is VIP approved?

Not as a single drug. ChEMBL lists synthetic VIP (aviptadil) at phase 3, the large trials ran in COVID-19. According to a review a combination of VIP and phentolamine is used for erectile dysfunction.

How does VIP work?

VIP binds to the receptors VPAC1 and VPAC2, which it shares with the related PACAP. There it mainly switches on the cAMP pathway. Nerves and immune cells release it. It widens vessels, stimulates glands and dampens inflammatory reactions.

What did the sarcoidosis study show?

20 patients with active sarcoidosis inhaled VIP for 4 weeks. It was safe and well tolerated, lung cells produced less TNF-alpha and the number of regulatory T cells in the lung rose. The study was open and had no placebo group.

Does VIP help in severe COVID-19?

The large TESICO trial with 471 people found no benefit as an infusion, after 90 days 38 versus 36 percent had died. An earlier trial with 196 people missed its main goal. Inhaled, VIP shortened the hospital stay from 10 to 7.8 days in a small study with 80 people.

What does VIP have to do with migraine?

In a study 21 people with migraine received a 2-hour infusion of VIP or placebo. After VIP 71 percent had a migraine attack, after placebo 5 percent. The temporal artery was widened. VIP and its receptors are therefore seen as possible targets for migraine drugs.

Which side effects are known?

Because VIP widens vessels, the regular entry lists a drop in blood pressure, flushing and dizziness. As a long infusion it often triggered attacks in people with migraine. In the large COVID-19 trial serious events by day 5 occurred in 63 versus 56 percent, without a significant difference.

Liittyvät

Samankaltaiset tuotteet